Product Code: ETC5359047 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The New Zealand Buprenorphine Market is likely to experience consistent growth rate gains over the period 2025 to 2029. Commencing at 3.68% in 2025, growth builds up to 5.47% by 2029.
The Buprenorphine market in New Zealand is projected to grow at a stable growth rate of 4.37% by 2027, highlighting the country's increasing focus on advanced technologies within the Asia region, where China holds the dominant position, followed closely by India, Japan, Australia and South Korea, shaping overall regional demand.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Buprenorphine Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Buprenorphine Market - Industry Life Cycle |
3.4 New Zealand Buprenorphine Market - Porter's Five Forces |
3.5 New Zealand Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 New Zealand Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 New Zealand Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 New Zealand Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 New Zealand Buprenorphine Market Trends |
6 New Zealand Buprenorphine Market Segmentations |
6.1 New Zealand Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 New Zealand Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 New Zealand Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 New Zealand Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 New Zealand Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 New Zealand Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 New Zealand Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 New Zealand Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 New Zealand Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 New Zealand Buprenorphine Market Import-Export Trade Statistics |
7.1 New Zealand Buprenorphine Market Export to Major Countries |
7.2 New Zealand Buprenorphine Market Imports from Major Countries |
8 New Zealand Buprenorphine Market Key Performance Indicators |
9 New Zealand Buprenorphine Market - Opportunity Assessment |
9.1 New Zealand Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 New Zealand Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 New Zealand Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 New Zealand Buprenorphine Market - Competitive Landscape |
10.1 New Zealand Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |